English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Join our expert talk on COVID-19 vaccines and CML on April 7th at 13.30 CET
March 2021 - The iCMLf continues to support the global CML community during the pandemic by providing the latest information on COVID-19 and CML. With the increasing availability of COVID-19 vaccines, up to date and relevant information is imperative for physicians treating blood cancers and their patients. The next highlight in our series of iCMLf Conversations is coming up with an expert talk on COVID-19 vaccines and CML to be held Wednesday, April 7th at 13.30 CET.
Don’t miss this opportunity to stay up to date with the latest developments on COVID-19 vaccines for people with CML.
iCMLf Conversation on CML:
Update on COVID-19 vaccines and CML
Date: Wednesday, April 7th at 13.30 Central European Time (CET)
23rd Annual John Goldman CML Conference: Call for abstracts
Mandelieu La Napoule - NEW DATES: October 7-10, 2021
Chairs: J. Cortes, T.P. Hughes, D.S. Krause
Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.
Deadline for Abstracts: May 8, 2021
Click here to submit your abstract
Contact: camille.dufour@univ-paris-diderot.fr
Equity for people living with a rare disease - February 28th is Rare Disease Day!
February 2021 - Today we join many other organizations supporting rare diseases and patients all over the world to raise awareness for rare diseases and their impact on patients lives.
There are over 300 million people living with a rare disease worldwide. Access to appropriate monitoring and treatment is still especially challenging in low- and middle-income countries.
CML is a rare condition and we will continue to improve access to treatment and care for patients affected by CML all over the world through our programs for physicians from the emerging regions and through our online education.
The 2021 Rowley Prize is awarded to Professor Susan Branford
February 2021 - The iCMLf is pleased to announce Professor Susan Branford, SA Pathology and Centre for Cancer Biology in Adelaide as the 2021 Rowley Prize winner. This annual prize awarded by the International CML Foundation recognises outstanding contributions to the understanding of the biology of CML. Sue is a leading international authority on molecular monitoring for CML and a major contributor to international collaborative initiatives to establish guidelines and recommendations for producing reliable molecular data.
The 2021 Goldman Prize is awarded to Professor Giuseppe Saglio
February 2021 - We are delighted to announce that Professor Giuseppe Saglio, Professor of Haematology and Internal Medicine at the University of Turin (Italy) has been awarded the 2021 Goldman Prize. The annual Goldman Prize, awarded in honour of Professor John Goldman, acknowledges outstanding contributions to the management of patients with CML and Professor Saglio is universally regarded as one of the greatest experts in CML treatment.
The 2021 iCMLf Prize is awarded to Dr Damira Bayzakova from Kyrgyzstan
February 2021 - The iCMLf Directors and Advisors have selected Dr Damira Bayzakova, a pediatric oncologist from the National Center of Oncology in Bishkek (Kyrgyzstan) as the 2021 iCMLf Prize winner. Dr Bayzakova has been awarded the prize posthumously for her efforts that greatly improved the monitoring and treatment of CML in Kyrgyzstan and to recognize her work and legacy. The iCMLf Prize recognizes outstanding contributions to the improvement of CML under the challenging conditions of low- and middle-income countries with unequal access to monitoring and access.
“Dr. Bayzakova was a CML specialist from Kyrgyzstan who tragically passed away in November 2020, due to complications of COVID-19. She dedicated her life to her patients and through her efforts greatly improved the treatment of CML in her country.” Pat Garcia-Gonzales, CEO, The Max Foundation
